CI Investments Inc
HZNP

CI Investments Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

CI Investments Inc’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,423
Closed -$512K – 1344
2023
Q3 		$512K Sell
4,423
-621
-12% -$66.7K ﹤0.01% 428
2023
Q2 		$519K Buy
5,044
+2,477
+96% +$261K ﹤0.01% 446
2023
Q1 		$280K Buy
2,567
+1,595
+164% +$176K ﹤0.01% 535
2022
Q4 		$111K Buy
972
+344
+55% +$28.6K ﹤0.01% 720
2022
Q3 		$39K Buy
628
+271
+76% +$18.9K ﹤0.01% 889
2022
Q2 		$28K Sell
357
-4,124
-92% -$391K ﹤0.01% 922
2022
Q1 		$471K Sell
4,481
-441
-9% -$43K ﹤0.01% 546
2021
Q4 		$530K Buy
4,922
+214
+5% +$23.3K ﹤0.01% 564
2021
Q3 		$516K Buy
4,708
+1,296
+38% +$135K ﹤0.01% 597
2021
Q2 		$319K Buy
+3,412
New +$314K ﹤0.01% 677
2020
Q4 		– Sell
-4,271
Closed -$332K – 1076
2020
Q3 		$332K Sell
4,271
-1,342
-24% -$92.3K ﹤0.01% 475
2020
Q2 		$312K Buy
+5,613
New +$240K ﹤0.01% 449

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

CI Investments Inc's HZNP Position: Q4 2023 in Review

CI Investments Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,423 shares — an estimated $512K sold.

CI Investments Inc first reported a position in HZNP in Q2 2020 and held it in 12 quarters. The position peaked at $530K in Q4 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • CI Investments Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • CI Investments Inc sold 4,423 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $512K.
  • CI Investments Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 12 quarters.
  • CI Investments Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $530K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on CI Investments Inc's 13F filing for Q4 2023, filed 12 Feb 2024.